Pharmacological reports : PR

Stress and brain inflammation linked to hormone and chemical changes in treatment-resistant depression

Updated

Abstract

Dysregulation of the HPA axis may contribute to treatment-resistant depression (TRD).

  • Many patients with depression do not get better with standard antidepressant medications.
  • Problems with stress response and inflammation could lead to brain damage and worsening depression.
  • Changes in how the body processes tryptophan may further harm brain function.
  • New treatments like ketamine and anti-inflammatory drugs may offer hope for TRD.
  • Understanding these complex interactions may help create personalized treatment plans for patients.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. AI-assisted writing disclosure: The authors declare that no AI-assisted technologies were used to prepare this manuscript. Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free